Table 1 Baseline characteristics.
 | Healthy controls | PCR-confirmed species | ||||
---|---|---|---|---|---|---|
P. falciparum | P. vivax | P. knowlesi | P. malariae | P. ovale | ||
Sample size (n) | 102 | 66 | 78 | 126 | 26 | 10 |
Gender (n of male [%]) | 45 (44) | 49 (74.2) | 56 (71.8) | 104 (82.5) | 19 (73.1) | 5 (55.6) |
Age (median [IQR]) | 31 (27–42) | 20.5 (13–39) | 18.5 (11.8–34) | 37 (22.8–50) | 17 (11.8–26.3) | 30 (24–43.5) |
Children, < 15 years (n [%]) | 0 (0) | 15 (22.7) | 20 (25.6) | 8 (6.3) | 9 (34.6) | 1 (11.1) |
Parasitemia, count/µL (median [IQR] [Range]) | 0 (0) | 12,000 (1,860–31,000) [0, 0–694] | 4,060 (2,090–8,170) [408–84,400] | 1,590 (118–14,700) [0, 27–584] | 1,380 (387–3,530) [71–12,600] | 3,120 (1,280–4,150) [276–5,030] |
Severe malaria (n [%]) | 0 (0) | 3 (4.5) | 1 (1.3) | 21 (16.7) | 0 | 0 |
Patients with plasma available (n [%]) | 102 (100) | 66 (100) | 77 (98.7) | 126 (100) | 26 (100) | 10 (100) |
Patients with whole blood available (n [%]) | 102 (100) | 63 (95.5) | 66 (84.6) | 66 (52.4) | 24 (92.3) | 2 (20) |